OR WAIT 15 SECS
© 2020 MJH Life Sciences and BioPharm International. All rights reserved.
© 2020 MJH Life Sciences™ and BioPharm International. All rights reserved.
Judy Glynn is senior principal scientist at Pfizer Global Research and Development Global Biologics, Bioprocess R&D
New technologies and adaptations of existing technologies can improve platform processes.
A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.
If certain engineering challenges can be addressed, precipitation may prove to be a valuable tool for antibody purification.